1. Home
  2. XBIT vs NDLS Comparison

XBIT vs NDLS Comparison

Compare XBIT & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.41

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$12.33

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
NDLS
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
68.7M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
XBIT
NDLS
Price
$2.41
$12.33
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
21.3K
59.2K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$495,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.37
52 Week Low
$2.09
$0.47
52 Week High
$3.61
$13.95

Technical Indicators

Market Signals
Indicator
XBIT
NDLS
Relative Strength Index (RSI) 38.96 62.93
Support Level $2.35 $0.60
Resistance Level $2.41 $13.95
Average True Range (ATR) 0.06 1.08
MACD -0.02 -0.12
Stochastic Oscillator 4.00 53.77

Price Performance

Historical Comparison
XBIT
NDLS

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

Share on Social Networks: